Kerala Medical Services Corporation dissolves drugs quality control unit

The Kerala Medical Services Corporation Limited (KMSCL) has dissolved its dedicated drugs quality control division, according to official announcements. The quality assurance function for pharmaceuticals procured by the corporation will now fall under the purview of the State Drugs Control department.

The decision to dismantle the internal quality control unit represents a restructuring of the corporation's operational framework. By consolidating drug quality oversight with the state regulatory body, authorities aim to streamline compliance and standardization processes across public medical procurement.

The State Drugs Control department, which operates under the state health ministry, is tasked with enforcing pharmaceutical regulations and maintaining quality standards for medicines across Kerala. The transfer of KMSCL's quality assurance mandate aligns drug testing procedures with the broader state regulatory framework.

KMSCL, a statutory body under the Kerala government, supplies medicines and medical equipment to public healthcare institutions across the state. The reorganization of its quality control function does not diminish oversight mechanisms but rather consolidates them within the established regulatory authority responsible for pharmaceutical standards in Kerala.